STOCK TITAN

FLAGU - $FLAGU STOCK NEWS

Welcome to our dedicated page for FLAGU news (Ticker: $FLAGU), a resource for investors and traders seeking the latest updates and insights on FLAGU stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FLAGU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FLAGU's position in the market.

Rhea-AI Summary
Calidi Biotherapeutics completes business combination with First Light Acquisition Group, securing approximately $28 million in gross proceeds. Calidi also secures forward purchase agreement for up to $10 million and intends to enter into a purchase agreement for up to $50 million. Common stock and warrants to commence trading on NYSE on September 13.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
First Light Acquisition Group anticipates completing its business combination with Calidi Biotherapeutics on September 12, 2023. Gross proceeds made available to Calidi Biotherapeutics from the transaction will total approximately $28 million. Calidi also secured a forward purchase agreement for up to $10 million. Common stock and warrants of Calidi approved for listing on the New York Stock Exchange American under the ticker symbols “CLDI” and “CLDI WS,” respectively, and expected to begin trading on September 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.66%
Tags
-
Rhea-AI Summary
Calidi Biotherapeutics secures $25 million in Series B funding led by Jackson Investment Group and Calidi Cure
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
FLAGU

NYSE:FLAGU

FLAGU Rankings

FLAGU Stock Data